ALOXI INJECTION 0.25mg (5ml vial)

Product Description

ALOXI INJECTION (Palonosetron) 0.25mg is an effective medication designed for the prevention of nausea and vomiting associated with chemotherapy and surgery. Each vial contains 5ml of the active ingredient, Palonosetron, which works by blocking the action of serotonin, a substance in the body that can trigger nausea and vomiting.

Indications

ALOXI is indicated for the prevention of:

• Acute nausea and vomiting associated with initial and repeat courses of cancer chemotherapy.
• Postoperative nausea and vomiting.

Mechanism of Action

Palonosetron, the active component of ALOXI, is a selective serotonin 5-HT3 receptor antagonist. By binding to these receptors, it helps to inhibit the signals that lead to nausea and vomiting, providing relief for patients undergoing treatments that may induce these symptoms.

Administration

ALOXI is administered as an intravenous injection. It is typically given as a single dose, and healthcare professionals will determine the appropriate timing and dosage based on individual patient needs.

Side Effects

Common side effects may include:

• Headache
• Dizziness
• Constipation
• Fatigue

Patients are advised to consult their healthcare provider if they experience any severe or persistent side effects.

Precautions

Prior to administration, inform your healthcare provider about any medical conditions, allergies, or medications you are currently taking to avoid potential interactions. ALOXI should be used with caution in patients with a history of cardiac issues.

Conclusion

ALOXI INJECTION 0.25mg is a trusted solution for managing nausea and vomiting in patients undergoing chemotherapy or surgery. Always follow your healthcare provider's instructions for use to ensure the best outcomes.